Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-02

Clinical Trial Update: Effect of Intravenous Nalbuphine on Emergence Agitation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous nalbuphine for emergence agitation after surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalbufyn (nalbuphine)

Snippet

Sponsor: Assiut University | Conditions: Postoperative Complications | Phase 2 | Status: COMPLETED